TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11910315

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Bendrofluazide
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 9814466

Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol injection (PEI)
Number of subjects: 41
Study: 7745464

Group type: EXPERIMENTAL
Intervention: Mechanical devices (e.g., graduated leg stockings; external pneumatic calf compression)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacological agents (e.g., low dose heparin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparins and heparinoids
Number of subjects: 0
Study: 2643933

Group type: EXPERIMENTAL
Intervention: Imipramine 0.5 mg/kg/d
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Imipramine 1.5 mg/kg/d
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Imipramine 3 mg/kg/d
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 1092731

Group type: EXPERIMENTAL
Intervention: Naproxen 400 mg daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 29439405

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (5000 IU/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 28165591

Group type: EXPERIMENTAL
Intervention: Proxima™ ultra‐short uncemented stem
Number of subjects: 25
Study: 25310394

Group type: EXPERIMENTAL
Intervention: Cervical Total Disk Replacement (Mobi-C Cervical Disc Prosthesis)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Anterior Cervical Discectomy and Fusion (ACDF)
Number of subjects: 245
Study: 24192245

Group type: EXPERIMENTAL
Intervention: Lichtenstein repair
Number of subjects: 282

Group type: COMPARATOR
Intervention: Onstep approach
Number of subjects: 282
Study: 21493191

Group type: EXPERIMENTAL
Intervention: Healthy Weight Assistant (HWA) intervention
Number of subjects: 297

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 297
Study: 19107337

Group type: EXPERIMENTAL
Intervention: Duodenal acidification (0.1 N HCl, 20 ml/min for 5 min)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Pure water infusion (20 ml/min for 5 min)
Number of subjects: 14
Study: 16449540

Group type: EXPERIMENTAL
Intervention: Modified-release tacrolimus (MR-4)
Number of subjects: 0
Study: 14521639

Group type: EXPERIMENTAL
Intervention: Video group (N = 112)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Internet group (N = 114)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Overall comparison
Number of subjects: 226
Study: 10999643

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment with a focus on maintaining diastolic blood pressure (DBP) above mid- to low 80s.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with DBP not lowered below mid- to low 80s.
Number of subjects: 0
Study: 8644831

Group type: EXPERIMENTAL
Intervention: Added-materials condition
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Imagery-based condition
Number of subjects: 21

Group type: COMPARATOR
Intervention: Rote exercise condition
Number of subjects: 21
Study: 1937790

Group type: EXPERIMENTAL
Intervention: Salmonella typhi Ty21a vaccine (10^9 CFU per dose, three doses)
Number of subjects: 18
Study: 6341435

Group type: EXPERIMENTAL
Intervention: Intranasal insufflation of 50 mg of dry ragweed or timothy grass pollen (antigen challenge)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Insufflation of pine pollen (control)
Number of subjects: 8
Study: 31436325

Group type: EXPERIMENTAL
Intervention: Baseline MRI parameters
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Completion of chemoradiotherapy (CRT)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Final multivariable model including significant variables
Number of subjects: 133
Study: 29273929

Group type: EXPERIMENTAL
Intervention: Autologous cultured fibroblasts
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 26735646

Group type: EXPERIMENTAL
Intervention: Greater family cohesion and flexibility
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Greater self-efficacy
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Higher self-efficacy
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Openness
Number of subjects: 472
Study: 25373830

Group type: EXPERIMENTAL
Intervention: Unleaded ammunition
Number of subjects: 55

Group type: COMPARATOR
Intervention: Leaded ammunition
Number of subjects: 55

Group type: COMPARATOR
Intervention: Modified unleaded ammunition
Number of subjects: 55
Study: 22607553

Group type: EXPERIMENTAL
Intervention: Senior centre group programme (weekly meetings)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 138
Study: 20847709

Group type: EXPERIMENTAL
Intervention: Daclizumab
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Sirolimus (rapamycin)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 13

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 13
Study: 17054896

Group type: EXPERIMENTAL
Intervention: 350‐mm(2) Baerveldt glaucoma implant
Number of subjects: 212

Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin C (MMC)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 212
Study: 16295223

Group type: EXPERIMENTAL
Intervention: Reinforced laryngeal mask airway (LMA) anesthesia
Number of subjects: 146

Group type: COMPARATOR
Intervention: Endotracheal intubation (El) anesthesia
Number of subjects: 146
Study: 11932320

Group type: EXPERIMENTAL
Intervention: Pegvisomant 20 mg/d for 7 d
Number of subjects: 6

Group type: COMPARATOR
Intervention: Octreotide 50 microg thrice daily for 7 d
Number of subjects: 6
Study: 11196128

Group type: EXPERIMENTAL
Intervention: High-Pass Resolution Perimetry (HRP)
Number of subjects: 68
Study: 7502230

Group type: EXPERIMENTAL
Intervention: Pelvic plus para‐aortic lymph nodes irradiation (para‐aortic group)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Pelvic irradiation (pelvic group)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Para‐aortic group
Number of subjects: 93

Group type: COMPARATOR
Intervention: Pelvic group
Number of subjects: 93
Study: 1724116

Group type: EXPERIMENTAL
Intervention: Astemizole (10 mg daily for 2 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 7130400

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29373060

Group type: EXPERIMENTAL
Intervention: Compressive Myofascial Release (CMR)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Graston Technique (GT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control
Number of subjects: 44
Study: 26031460

Group type: EXPERIMENTAL
Intervention: MLN3897 (CP moiety)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: MLN3897 (TC moiety)
Number of subjects: 12
Study: 23527873

Group type: EXPERIMENTAL
Intervention: Dual handrim wheelchair
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lever drive wheelchair
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Neater Uni-wheelchair (NUW)
Number of subjects: 15
Study: 22691058

Group type: EXPERIMENTAL
Intervention: Adjunctive application of locally delivered minocycline ointment in association with flap surgery (FM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Flap surgery only (FO)
Number of subjects: 20
Study: 19875102

Group type: EXPERIMENTAL
Intervention: Traditional cognitive skills workbook
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-traditional cognitive skills workbook
Number of subjects: 0

Group type: COMPARATOR
Intervention: Academic skills workbook
Number of subjects: 0
Study: 19264565

Group type: EXPERIMENTAL
Intervention: Pre-incisional infiltration with levobupivacaine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Post-operative infiltration with levobupivacaine
Number of subjects: 50
Study: 16437375

Group type: EXPERIMENTAL
Intervention: Glutamine (30 g/d) for 7 days
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (no glutamine)
Number of subjects: 39
Study: 15215812

Group type: EXPERIMENTAL
Intervention: Glucose-insulin-potassium (GIK) therapy
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: GIK therapy
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: GIK therapy (in diabetic patients)
Number of subjects: 312
Study: 10902791

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens started at age 15 years
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens started at age 12 years
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: GH therapy before estrogen treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Historical control patients (age-matched)
Number of subjects: 60
Study: 8888720

Group type: EXPERIMENTAL
Intervention: nizatidine 300 mg at night
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: omeprazole 20 mg in the morning
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: nizatidine 300 mg at night and omeprazole 20 mg in the morning
Number of subjects: 23
Study: 1546823

Group type: EXPERIMENTAL
Intervention: Nasal provocation (allergen-induced nasal reactivity)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Repeat nasal challenges
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Specific nasal challenge
Number of subjects: 27
Study: 3906942

Group type: EXPERIMENTAL
Intervention: Indoprofen (400 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Pethidine (1.5 mg/kg)
Number of subjects: 80
Study: 3305488

Group type: EXPERIMENTAL
Intervention: Propranolol (80, 160, or 320 mg/day)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide (30, 45, or 75 mg/day)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study: 28762135

Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg once daily
Number of subjects: 11

Group type: COMPARATOR
Intervention: Everolimus 5 mg twice daily
Number of subjects: 11
Study: 27582675

Group type: EXPERIMENTAL
Intervention: Combined therapy (1 intravitreal bevacizumab injection 1.25 mg + PDT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Intravitreal bevacizumab monotherapy
Number of subjects: 62
Study: 24697819

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine alone
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dexmedetomidine plus midazolam
Number of subjects: 24
Study: 22544804

Group type: EXPERIMENTAL
Intervention: Tenofovir DF 300 mg once daily for 72 weeks
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo once daily for 72 weeks
Number of subjects: 106
Study: 19760359

Group type: EXPERIMENTAL
Intervention: Mediterranean diet intervention (MeDiet)
Number of subjects: 1048
Study: 18442423

Group type: EXPERIMENTAL
Intervention: Continuous Passive Motion (CPM) + Physiotherapy (PT) for 17 consecutive days after surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Physiotherapy (PT) alone after usual care in the first two weeks post-discharge
Number of subjects: 60
Study: 15721096

Group type: EXPERIMENTAL
Intervention: Atazanavir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nelfinavir
Number of subjects: 0
Study: 14502837

Group type: EXPERIMENTAL
Intervention: Phonological awareness tasks adapted from literature
Number of subjects: 9
Study: 10707917

Group type: EXPERIMENTAL
Intervention: Prescription NSAIDs
Number of subjects: 11898

Group type: EXPERIMENTAL
Intervention: Ibuprofen (dosages < or =1,200 mg/day)
Number of subjects: 11898

Group type: EXPERIMENTAL
Intervention: Ibuprofen (dosages >1,200-<2,400 mg/day)
Number of subjects: 11898

Group type: EXPERIMENTAL
Intervention: Ibuprofen (dosages > or =2,400 mg/day)
Number of subjects: 11898

Group type: COMPARATOR
Intervention: Population controls (no NSAID use)
Number of subjects: 11898
Study: 9195347

Group type: EXPERIMENTAL
Intervention: 2 mg/kg i.v. lidocaine 90 seconds prior to endotracheal intubation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 60
Study: 1287615

Group type: EXPERIMENTAL
Intervention: Cefaclor AF (750 mg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cefaclor AF (500 mg) alone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cefaclor AF with cimetidine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cefaclor AF with Maalox TC
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cefaclor immediate release (500 mg) alone
Number of subjects: 40
Study: 3519451

Group type: EXPERIMENTAL
Intervention: CL 115347 (prostaglandin E2 analogue)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 30632023

Group type: EXPERIMENTAL
Intervention: Palbociclib plus letrozole
Number of subjects: 666

Group type: COMPARATOR
Intervention: Placebo plus letrozole
Number of subjects: 666
Study: 30620870

Group type: EXPERIMENTAL
Intervention: Dual Zinc plus Arginine dentifrice
Number of subjects: 80

Group type: COMPARATOR
Intervention: Regular fluoride dentifrice
Number of subjects: 80
Study: 28639860

Group type: EXPERIMENTAL
Intervention: Modified Conconi test (CT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Prolonged exercise test (PET)
Number of subjects: 12
Study: 25350539

Group type: EXPERIMENTAL
Intervention: Professional intervention (trained research assistant provided distraction)
Number of subjects: 574

Group type: COMPARATOR
Intervention: Basic intervention (parents trained on providing distraction)
Number of subjects: 574

Group type: COMPARATOR
Intervention: Enhanced intervention (basic training plus tailored instructions, environmental modifications, and support)
Number of subjects: 574
Study: 23883636

Group type: EXPERIMENTAL
Intervention: Exercise intervention (60-minute comprehensive exercise program, twice a week for 3 months)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Exercise + amino acid supplementation (6 g/day for 3 months)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Amino acid supplementation (6 g/day for 3 months)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 155
Study: 21046171

Group type: EXPERIMENTAL
Intervention: Modafinil 100 mg once daily
Number of subjects: 37
Study: 18029066

Group type: EXPERIMENTAL
Intervention: Study vaccine (Group 1)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Vero cells vaccine (Group 2)
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 296
Study: 16271155

Group type: EXPERIMENTAL
Intervention: Local steroid treatment (fluticasone) for 4 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Nasal biopsies from patients with allergic rhinitis
Number of subjects: 42

Group type: COMPARATOR
Intervention: Nasal biopsies from healthy volunteers
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Nasal polyps
Number of subjects: 42
Study: 12114411

Group type: EXPERIMENTAL
Intervention: S-1 administered once daily at a dose of 50 mg/m2/day for 21 consecutive days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: S-1 administered once daily at a dose of 60 mg/m2/day for 21 consecutive days
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Pharmacokinetic analysis of S-1
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Correlation analysis of diarrhea grade with pharmacokinetics
Number of subjects: 18
Study: 11123415

Group type: EXPERIMENTAL
Intervention: Hydrogel barrier/repair cream
Number of subjects: 80

Group type: COMPARATOR
Intervention: Petrolatum-based cream
Number of subjects: 80
Study: 8737631

Group type: EXPERIMENTAL
Intervention: 1000 mg/d HR
Number of subjects: 137

Group type: COMPARATOR
Intervention: 1000 mg/d and 500 mg/d HR
Number of subjects: 137

Group type: COMPARATOR
Intervention: 600 mg/d HCE
Number of subjects: 137
Study: 1327655

Group type: EXPERIMENTAL
Intervention: S-adenosyl-L-methionine (oral administration)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Untreated patients (control group)
Number of subjects: 13
Study: 3994782

Group type: EXPERIMENTAL
Intervention: Endurance physical training (4 months, 3 times/week for 1-hour sessions)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (11 patients with similar characteristics)
Number of subjects: 10
Study: 31110092

Group type: EXPERIMENTAL
Intervention: Mifamurtide combined with postoperative chemotherapy
Number of subjects: 126

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 126
Study: 27707990

Group type: EXPERIMENTAL
Intervention: Ceftolozane/tazobactam (1.5 g IV every 8 h)
Number of subjects: 1346

Group type: COMPARATOR
Intervention: Levofloxacin (750 mg once daily)
Number of subjects: 1346

Group type: COMPARATOR
Intervention: Meropenem (1 g IV every 8 h)
Number of subjects: 1346
Study: 26666319

Group type: EXPERIMENTAL
Intervention: Prednisolone (1 mg/kg per day)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 24157825

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Metformin (in women without insulin resistance)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (in women without insulin resistance)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Metformin (in women with insulin resistance)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (in women with insulin resistance)
Number of subjects: 100
Study: 20808151

Group type: EXPERIMENTAL
Intervention: Bibliotherapy (information leaflet and self-help manual 'Coping with Depression')
Number of subjects: 170

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 170
Study: 19537838

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Duloxetine 60 or 120 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 0
Study: 16953132

Group type: EXPERIMENTAL
Intervention: Comprehensive lifestyle modification program (16 weeks, weekly meetings, individually prescribed exercise and diet, stress management, self-monitoring)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 34
Study: 12773196

Group type: EXPERIMENTAL
Intervention: 1 microg/kg ghrelin
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 5 microg/kg ghrelin
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 10 microg/kg ghrelin
Number of subjects: 6
Study: 10839470

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg 12‐hourly for 48 hours
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 35
Study: 10322847

Group type: EXPERIMENTAL
Intervention: Jiangtangkang (JTK), 8 g each time, 3 times per day for 2 months
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control group (Glibenclazide for newly discovered NIDDM, no treatment for poorly controlled NIDDM)
Number of subjects: 188
Study: 8489450

Group type: EXPERIMENTAL
Intervention: PhXA41 (0.006%) twice daily during week 1 and pilocarpine (2%) three times daily during week 2
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pilocarpine (2%) three times daily during week 1 and PhXA41 (0.006%) twice daily during week 2
Number of subjects: 20
Study: 3501692

Group type: EXPERIMENTAL
Intervention: Cimetidine and antacid
Number of subjects: 106

Group type: COMPARATOR
Intervention: Antacid
Number of subjects: 106
Study: 31718504

Group type: EXPERIMENTAL
Intervention: Journal interventions (e.g., Basic Science Checklist by Stroke)
Number of subjects: 4162

Group type: COMPARATOR
Intervention: Control journals (without analogous interventions)
Number of subjects: 4162
Study: 29394998

Group type: EXPERIMENTAL
Intervention: heparin + a glycoprotein IIb/IIIa inhibitor
Number of subjects: 3602

Group type: COMPARATOR
Intervention: bivalirudin
Number of subjects: 3602
Study: 27117698

Group type: EXPERIMENTAL
Intervention: CT-P13 (5 mg/kg) administered intravenously every 8 weeks from week 62 to week 102
Number of subjects: 174
Study: 25586332

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT) with microskin autografting
Number of subjects: 81

Group type: COMPARATOR
Intervention: Conventional gauze with microskin autografting
Number of subjects: 81
Study: 24257391

Group type: EXPERIMENTAL
Intervention: Pudendal nerve block (PNB) with 0.3 mL/kg 0.25% bupivacaine and 1 µg/kg clonidine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Caudal block (CB) with 1 mL/kg 0.25% bupivacaine and 1 µg/kg clonidine
Number of subjects: 80
Study: 20876551

Group type: EXPERIMENTAL
Intervention: Education and counseling intervention provided by a lactation consultant-peer counselor team
Number of subjects: 289

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 289
Study: 18571296

Group type: EXPERIMENTAL
Intervention: Immunostimulating diet (IMEN group)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Standard oligopeptic diet (SEN group)
Number of subjects: 183
Study: 17138304

Group type: EXPERIMENTAL
Intervention: Instrumental music with vocals
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Instrumental music without vocals
Number of subjects: 2

Group type: COMPARATOR
Intervention: Both types of music
Number of subjects: 2
Study: 12892243

Group type: EXPERIMENTAL
Intervention: Upper limb interval training (3 sessions of 30 minutes per week for 6 weeks)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Upper limb interval training
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (general rehabilitation only)
Number of subjects: 14
Study: 11054030

Group type: EXPERIMENTAL
Intervention: Combination therapy (imipramine plus oxybutynin)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Monotherapy
Number of subjects: 77
Study: 9202790

Group type: EXPERIMENTAL
Intervention: High-density formula (30 kcal/oz) at 145 ml/kg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-density formula (24 kcal/oz) at 180 ml/kg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-density formula (30 kcal/oz)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-density formula (24 kcal/oz)
Number of subjects: 60